Camlin Fine Sciences is currently trading at Rs. 91.60, up by 0.70 points or 0.77% from its previous closing of Rs. 90.90 on the BSE.
The scrip opened at Rs. 92.00 and has touched a high and low of Rs. 92.85 and Rs. 91.60 respectively. So far 3827 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 119.60 on 26-Oct-2016 and a 52 week low of Rs. 82.65 on 29-Sep-2016.
Last one week high and low of the scrip stood at Rs. 92.95 and Rs. 89.00 respectively. The current market cap of the company is Rs. 942.72 crore.
The promoters holding in the company stood at 40.91%, while institutions and non-institutions held 12.25% and 46.84% respectively.
Camlin Fine Sciences is planning to raise up to Rs 250 crore by way of QIP/GDR/ADR/FCCB/other securities linked to equity / preference shares / any instrument or securities representing convertible securities. The board of directors of the company in their meeting, scheduled to be held on May 19, 2017, will consider the same.
Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).
Company Name | CMP |
---|---|
Tata Chemicals | 1069.40 |
SRF | 2165.85 |
Pidilite Inds. | 2958.60 |
Aarti Inds | 430.80 |
Atul | 7261.00 |
View more.. |